Achieving Value in the Management of Chronic HCV Infection

Achieving value in the management of chronic HCV infection is one of the most complex challenges facing health plans today. Listen as AJ Ally, R.Ph, MBA, Vice President of Clinical Programs at DST’s Argus Health, talks about the balancing act between treating to cure and cost-effective management with a strategic focus on identifying and eliminating waste by using a Center of Excellence model to coordinate efforts of physicians, pharmacists and patients. 

Visit www.dsthealth.com to learn more. 

Sources

• CDC https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm
• AASLD and IDSA Guidelines http://www.hcvguidelines.org/
• Kaiser Health News http://khn.org/news/medicaid-private-insurers-begin-to-lift-curbs-on-pricey-hepatitis-c-drugs/
• CDC https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm